IL17A and hepatocellular carcinoma: M2 tumor-associated macrophages in the tumor microenvironment can secrete the proinflammatory cytokine IL-17 (interleukin-17), which induces drug resistance in tumor cells by activating the CMA pathway and thus reducing apoptosis of HCC cells [33].